These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3103528)

  • 1. The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography.
    Chugani HT; Mazziotta JC; Engel J; Phelps ME
    Ann Neurol; 1987 Jan; 21(1):4-13. PubMed ID: 3103528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral glucose metabolism in the Lennox-Gastaut syndrome.
    Theodore WH; Rose D; Patronas N; Sato S; Holmes M; Bairamian D; Porter RJ; Di Chiro G; Larson S; Fishbein D
    Ann Neurol; 1987 Jan; 21(1):14-21. PubMed ID: 3103526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local cerebral metabolic rate for glucose during petit mal absences.
    Engel J; Lubens P; Kuhl DE; Phelps ME
    Ann Neurol; 1985 Feb; 17(2):121-8. PubMed ID: 3919636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral glucose metabolism in five patients with Lennox-Gastaut syndrome.
    Iinuma K; Yanai K; Yanagisawa T; Fueki N; Tada K; Ito M; Matsuzawa T; Ido T
    Pediatr Neurol; 1987; 3(1):12-8. PubMed ID: 3149469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lennox-Gastaut syndrome and positron emission tomography.
    Ferrendelli JA
    Ann Neurol; 1987 Jan; 21(1):3. PubMed ID: 3103527
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebellar and brainstem hypometabolism in olivopontocerebellar atrophy detected with positron emission tomography.
    Gilman S; Markel DS; Koeppe RA; Junck L; Kluin KJ; Gebarski SS; Hichwa RD
    Ann Neurol; 1988 Mar; 23(3):223-30. PubMed ID: 3259853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes.
    Engel J; Kuhl DE; Phelps ME; Mazziotta JC
    Ann Neurol; 1982 Dec; 12(6):510-7. PubMed ID: 6818896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of positron emission tomography in sarcomas.
    Schuetze SM
    Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital perisylvian syndrome: MRI and glucose PET correlations.
    Luat AF; Bernardi B; Chugani HT
    Pediatr Neurol; 2006 Jul; 35(1):21-9. PubMed ID: 16814081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3.
    Kuhl DE; Engel J; Phelps ME; Selin C
    Ann Neurol; 1980 Oct; 8(4):348-60. PubMed ID: 6776878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of local cerebral glucose utilization by positron emission tomography of [18F]2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures.
    Wienhard K; Pawlik G; Herholz K; Wagner R; Heiss WD
    J Cereb Blood Flow Metab; 1985 Mar; 5(1):115-25. PubMed ID: 3871780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy.
    Abou-Khalil BW; Siegel GJ; Sackellares JC; Gilman S; Hichwa R; Marshall R
    Ann Neurol; 1987 Oct; 22(4):480-6. PubMed ID: 3124709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
    Blomqvist G; Stone-Elander S; Halldin C; Roland PE; Swahn CG; Haaparanta M; Solin O; Lindqvist M; Widén L
    Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional brain glucose utilization in adenylosuccinase-deficient patients measured by positron emission tomography.
    De Volder AG; Jaeken J; Van den Berghe G; Bol A; Michel C; Cogneau M; Goffinet AM
    Pediatr Res; 1988 Aug; 24(2):238-42. PubMed ID: 3263613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontoparietal
    Balfroid T; Warren AEL; Dalic LJ; Aeby A; Berlangieri SU; Archer JS
    Epilepsy Res; 2023 May; 192():107131. PubMed ID: 37054522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local cerebral glucose utilization in rats with petit mal-like seizures.
    Nehlig A; Vergnes M; Marescaux C; Boyet S; Lannes B
    Ann Neurol; 1991 Jan; 29(1):72-7. PubMed ID: 1899987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.
    Phelps ME; Huang SC; Hoffman EJ; Selin C; Sokoloff L; Kuhl DE
    Ann Neurol; 1979 Nov; 6(5):371-88. PubMed ID: 117743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocorticographic confirmation of focal positron emission tomographic abnormalities in children with intractable epilepsy.
    Olson DM; Chugani HT; Shewmon DA; Phelps ME; Peacock WJ
    Epilepsia; 1990; 31(6):731-9. PubMed ID: 2245803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.